ArticleAmerican journal of hematology2026

CSF ctDNA Molecular Clearance as a Prognostic Biomarker for Orelabrutinib-Treated Primary Central Nervous System Lymphoma: Insights From Comparison With PET-CT.

Lixia Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.